Tocol Pharmaceuticals

Tocol Pharmaceuticals is a private U.S. pharmaceutical company focused on developing plant-derived tocol compositions, including tocotrienol- and tocopherol-rich fractions, for radioprotection and mitigation of radiation injury. The company appears to be centered on natural-product small-molecule formulations sourced from rice bran oil distillate and related vitamin E compounds, supported by a portfolio of U.S. and international patents. Its lead development theme is protection against radiation exposure and oxidative damage, with work described in patent literature rather than a clearly disclosed late-stage clinical pipeline. The company also presents itself as having pharmaceutical development expertise and contract-based development capabilities. Overall, Tocol is best characterized as an early-stage, private radioprotective therapeutics company operating at the interface of nutraceutical chemistry and pharmaceutical development.